These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23266372)

  • 1. Tuberculosis 2012: biology, pathogenesis and intervention strategies; an update from the city of light.
    Gouzy A; Nigou J; Gilleron M; Neyrolles O; Tailleux L; Gordon SV
    Res Microbiol; 2013 Apr; 164(3):270-80. PubMed ID: 23266372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming the global crisis: "yes, we can", but also for TB ... ?
    Ottenhoff TH
    Eur J Immunol; 2009 Aug; 39(8):2014-20. PubMed ID: 19672895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards new tuberculosis vaccines.
    Svenson S; Källenius G; Pawlowski A; Hamasur B
    Hum Vaccin; 2010 Apr; 6(4):309-17. PubMed ID: 20372087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To fight tuberculosis, fund basic research.
    Grundner C
    PLoS Biol; 2018 Sep; 16(9):e3000037. PubMed ID: 30252891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Human Primate Models of Tuberculosis.
    Peña JC; Ho WZ
    Microbiol Spectr; 2016 Aug; 4(4):. PubMed ID: 27726820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbe Profile: Mycobacterium tuberculosis: Humanity's deadly microbial foe.
    Gordon SV; Parish T
    Microbiology (Reading); 2018 Apr; 164(4):437-439. PubMed ID: 29465344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetics of Mycobacterium tuberculosis pathogenesis.
    Clark-Curtiss JE; Haydel SE
    Annu Rev Microbiol; 2003; 57():517-49. PubMed ID: 14527290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development.
    Dietrich J; Doherty TM
    APMIS; 2009 May; 117(5-6):440-57. PubMed ID: 19400867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological consequences of strain variation within the Mycobacterium tuberculosis complex.
    Tientcheu LD; Koch A; Ndengane M; Andoseh G; Kampmann B; Wilkinson RJ
    Eur J Immunol; 2017 Mar; 47(3):432-445. PubMed ID: 28150302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis in Africa: learning from pathogenesis for biomarker identification.
    Kaufmann SH; Parida SK
    Cell Host Microbe; 2008 Sep; 4(3):219-28. PubMed ID: 18779048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meeting report: 5th Global Forum on TB Vaccines, 20-23 February 2018, New Delhi India.
    Atmakuri K; Penn-Nicholson A; Tanner R; Dockrell HM
    Tuberculosis (Edinb); 2018 Dec; 113():55-64. PubMed ID: 30514514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in tuberculosis vaccine strategies.
    Skeiky YA; Sadoff JC
    Nat Rev Microbiol; 2006 Jun; 4(6):469-76. PubMed ID: 16710326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Learning from epidemiological, clinical, and immunological studies on Mycobacterium africanum for improving current understanding of host-pathogen interactions, and for the development and evaluation of diagnostics, host-directed therapies, and vaccines for tuberculosis.
    Zumla A; Otchere ID; Mensah GI; Asante-Poku A; Gehre F; Maeurer M; Bates M; Mwaba P; Ntoumi F; Yeboah-Manu D
    Int J Infect Dis; 2017 Mar; 56():126-129. PubMed ID: 27979782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human biomarkers: can they help us to develop a new tuberculosis vaccine?
    Fletcher HA; Dockrell HM
    Future Microbiol; 2016 Jun; 11():781-7. PubMed ID: 27203133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium tuberculosis infection and vaccine development.
    Tang J; Yam WC; Chen Z
    Tuberculosis (Edinb); 2016 May; 98():30-41. PubMed ID: 27156616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in tuberculosis research in India.
    Tyagi AK; Dhar N
    Adv Biochem Eng Biotechnol; 2003; 84():211-73. PubMed ID: 12934938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Achieving STOP TB Partnership goals: perspectives on development of new diagnostics, drugs and vaccines for tuberculosis.
    Mwaba P; McNerney R; Grobusch MP; O'Grady J; Bates M; Kapata N; Maeurer M; Zumla A
    Trop Med Int Health; 2011 Jul; 16(7):819-27. PubMed ID: 21489070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization strategies against pulmonary tuberculosis: considerations of T cell geography.
    Horvath CN; Xing Z
    Adv Exp Med Biol; 2013; 783():267-78. PubMed ID: 23468114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.